Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease-Reference-Cited by-同舟云学术

Laquinimod has no effects on brain volume or cellular CNS composition in the F1 3xTg-AD/C3H mouse model of Alzheimer's disease

Published:2017-08 Issue: Volume:309 Page:100-110
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Hussain Rehana Z.,Miller-Little William A.,Lambracht-Washington Doris,Jaramillo Tom C.,Takahashi Masaya,Zhang Shanrong,Fu Min,Cutter Gary R.,Hayardeny Liat,Powell Craig M.,Rosenberg Roger N.,Stüve Olaf

Funder

Teva Pharmaceuticals

U.S. Department of Veterans Affairs

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference32 articles.

1. The immunomodulatory effect of laquinimod in CNS autoimmunity is mediated by the aryl hydrocarbon receptor;Berg;J. Neuroimmunol.,2016

2. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides;Bjork;PLoS Biol.,2009

3. Insight into the mechanism of laquinimod action;Bruck;J. Neurol. Sci.,2011

4. Reduced astrocytic NF-kappaB activation by laquinimod protects from cuprizone-induced demyelination;Bruck;Acta Neuropathol.,2012

5. The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis;Brunmark;J. Neuroimmunol.,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression of Alzheimer's disease and effect of scFv‐h3D6 immunotherapy in the 3xTg‐AD mouse model: An in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy;NMR in Biomedicine;2020-02-17

2. Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populations;Therapeutic Advances in Neurological Disorders;2020-01

3. Laquinimod Supports Remyelination in Non-Supportive Environments;Cells;2019-10-31

4. Activation of the miR-34a-Mediated SIRT1/mTOR Signaling Pathway by Urolithin A Attenuates d-Galactose-Induced Brain Aging in Mice;Neurotherapeutics;2019-07-01

5. Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE;Neurology - Neuroimmunology Neuroinflammation;2018-01-18